Development and validation of a novel anaerobic carbapenem inactivation method (Ana-CIM) for the detection of carbapenemase production in Bacteroides fragilis

Authors

Allison R Eberly, Mayo Clinic
Meghan A Wallace, Washington University School of Medicine in St. Louis
Samantha Shannon, Mayo Clinic
Angela K Heitman, Mayo Clinic
Audrey N Schuetz, Mayo Clinic
Carey-Ann D Burnham, Washington University School of Medicine in St. Louis
Sophonie Jean, The Ohio State University

Journal

Journal of clinical microbiology

Publication Date

4-20-2022

Volume

60

Issue

4

First Page

e0218821

Document Type

Open Access Publication

DOI

10.1128/jcm.02188-21

Rights and Permissions

Eberly AR, Wallace MA, Shannon S, Heitman AK, Schuetz AN, Burnham CD, Jean S. Development and Validation of a Novel Anaerobic Carbapenem Inactivation Method (Ana-CIM) for the Detection of Carbapenemase Production in Bacteroides fragilis. J Clin Microbiol. 2022 Apr 20;60(4):e0218821. doi.org/10.1128/jcm.02188-21

Recommended Citation

Eberly, Allison R; Wallace, Meghan A; Shannon, Samantha; Heitman, Angela K; Schuetz, Audrey N; Burnham, Carey-Ann D; and Jean, Sophonie, "Development and validation of a novel anaerobic carbapenem inactivation method (Ana-CIM) for the detection of carbapenemase production in Bacteroides fragilis." Journal of clinical microbiology. 60, 4. e0218821 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11942